Clinical trial / 2011
Flaxseed supplementation reduced insulin resistance and oxidative stress marker TBARS in obese glucose-intolerant individuals.
In a randomized crossover design, nine obese glucose intolerant individuals consumed 40 g of ground flaxseed or 40 g of wheat bran daily for 12 weeks with a 4-week washout period. Flaxseed supplementation decreased TBARS (p = 0.0215) and HOMA-IR (p = 0.0382), though neither supplement changed plasma inflammatory biomarkers (CRP, TNF-alpha, IL-6). A positive correlation was observed between TBARS and HOMA-IR (r = 0.62, p = 0.0003).
- Study type
- Randomized crossover trial
- Who was studied
- Nine obese glucose intolerant people
- What was measured
- Plasma inflammatory biomarkers (CRP, TNF-alpha, IL-6), glucose, insulin, and TBARS
THE PAPER
Flaxseed supplementation improved insulin resistance in obese glucose intolerant people: a randomized crossover design.
Rhee Y, Brunt A. Nutr J, 2011.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.